EFFICACY AND SAFETY OF TABALUMAB, AN ANTI-B CELL ACTIVATING FACTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO TNF-ALPHA INHIBITORS: RESULTS FROM A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY

Autor:	Schiff, M., Combe, B., Dorner, T., Kremer, J.M., Huizinga, T.W., Veenhuizen, M., Gill, A., Zou, H., Komocsar, W., Berclaz, P.Y., Ortmann, R., Lee, C.
Jazyk:	angličtina
Rok vydání:	2014
Zdroj:	Annals of the Rheumatic Diseases, 73, 952-953
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3a6a1776ff4c9993a6a03455fe6ef5c8 https://hdl.handle.net/1887/101707 Zobrazit plný text záznamu